ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01060462
Recruitment Status : Completed
First Posted : February 2, 2010
Last Update Posted : May 15, 2014
Sponsor:
Information provided by (Responsible Party):
Janssen Korea, Ltd., Korea